Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06413095
Status:
COMPLETED
Last Update Posted:
2024-05-14
First Post:
2024-04-01
Brief Title:
PBI-MST-01 NCT04541108 Substudy MSD-03 Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS
Sponsor:
Presage Biosciences
Organization:
Presage Biosciences
Organization Data
Organization:
Presage Biosciences
Class:
INDUSTRY
Study ID:
MST01-MSD-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Presage Biosciences
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Merck Sharp Dohme LLC | INDUSTRY |